The potential of soluble epoxide hydrolase inhibition in the treatment of cardiac hypertrophy

Congest Heart Fail. 2008 Jul-Aug;14(4):219-24. doi: 10.1111/j.1751-7133.2008.08430.x.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Cardiomegaly / drug therapy*
  • Endothelium / drug effects
  • Epoxide Hydrolases / antagonists & inhibitors*
  • Humans
  • Recombinant Proteins / therapeutic use*

Substances

  • Recombinant Proteins
  • Epoxide Hydrolases